Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 6/6/2020 5:00:00 PM
.@HarvardHealth explains how #exercise can help treat #anxiety:
BCH Innovation News @BCH_Innovation 6/6/2020 3:00:00 PM
Researchers find that #infants as young as 6-months-old, can tell the difference between musical notes:…
BCH Innovation News @BCH_Innovation 6/5/2020 6:00:00 PM
Some children exhibit immune dysregulation and hyperinflammation several weeks after #COVID19 exposure. Some guidan…
BCH Innovation News @BCH_Innovation 6/5/2020 4:00:00 PM
.@medpagetoday reports on a recent study that suggests excess risk for #COVID19-associated multisystem inflammatory…
BCH Innovation News @BCH_Innovation 6/4/2020 6:00:00 PM
Edward Lee and Alexandra Foust of @BostonChildrens collaborate with international colleagues to develop a consensus…
BCH Innovation News @BCH_Innovation 6/4/2020 3:00:00 PM
“Because MIS-C is an entirely new condition, we are using medications that are effective in other inflammatory synd…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer